PCN35 VALUATION OF SOCIETAL PREFERENCE BETWEEN THERAPIES FOR CANCER-RELATED ANAEMIA (CRA)- RECOMBINANT HUMAN ERYTHROPOETIN (RH-EPO) VERSUS BLOOD TRANSFUSION
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65768-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)65768-3/fulltext
Title :
PCN35 VALUATION OF SOCIETAL PREFERENCE BETWEEN THERAPIES FOR CANCER-RELATED ANAEMIA (CRA)- RECOMBINANT HUMAN ERYTHROPOETIN (RH-EPO) VERSUS BLOOD TRANSFUSION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65768-3&doi=10.1016/S1098-3015(10)65768-3
First page :
Section Title :
Open access? :
No
Section Order :
135